PAI announced three biopharma companies have pooled $500,000 for the final development phase of its hēRo3, a new open-source platform for running cost-effectiveness models.
The platform is slated to undergo extensive testing in October by PAI’s development partners and HTA agencies.
After testing, according to PAI, the platform will be released for personal use and for enterprises.
“Health economics modeling will never be the same,” PAI says.
